GLPwatch
The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy.
Diabetes Res Clin Pract · 2014
Last updated 2026-05-28A study found that rapid improvement in blood sugar control with GLP-1 drugs may temporarily worsen diabetic retinopathy, an eye condition caused by diabetes. This worsening is not permanent, and the condition may improve again with continued use of the drug. People with existing eye swelling, more severe retinopathy, or a longer history of diabetes may be at higher risk of lasting damage.
AI summary of the abstract below.
| Journal | Diabetes Res Clin Pract, 2014 |
|---|---|
| Citations | 44 |
| Relative citation ratio | 1.63 |
| NIH percentile | 67 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Abstract
Rapid improvement in glycaemic control with GLP-1 receptor agonist (RA) therapy has been reported to be associated with significant progression of diabetic retinopathy. This deterioration is transient, and continuing GLP-1 RA treatment is associated with reversal of this phenomenon. Pre-existent maculopathy, higher grade of retinopathy and longer duration of diabetes may be risk factors for persistent deterioration.
Verbatim abstract via PubMed 24456992 ↗